Your browser doesn't support javascript.
loading
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.
Samsky, Marc D; Krucoff, Mitchell W; Morrow, David A; Abraham, William T; Aguel, Fernando; Althouse, Andrew D; Chen, Eric; Cigarroa, Joaquin E; DeVore, Adam D; Farb, Andrew; Gilchrist, Ian C; Henry, Timothy D; Hochman, Judith S; Kapur, Navin K; Morrow, Valarie; Ohman, E Magnus; O'Neill, William W; Piña, Ileana L; Proudfoot, Alastair G; Sapirstein, John S; Seltzer, Jonathan H; Senatore, Fred; Shinnar, Meir; Simonton, Charles A; Tehrani, Behnam N; Thiele, Holger; Truesdell, Alexander G; Waksman, Ron; Rao, Sunil V.
Affiliation
  • Samsky MD; Duke University Medical Center, Duke Clinical Research Institute, Durham Veterans Administration, Durham, NC. Electronic address: marc.samsky@duke.edu.
  • Krucoff MW; Duke University Medical Center, Cardiovascular Devices Unit, eECG Core Laboratories, Duke Clinical Research Institute, Durham, NC. Electronic address: mitchell.krucoff@duke.edu.
  • Morrow DA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: DMORROW@BWH.HARVARD.EDU.
  • Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH. Electronic address: william.abraham@osumc.edu.
  • Aguel F; U.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD. Electronic address: fernando.aguel@fda.hhs.gov.
  • Althouse AD; Center for Research on Healthcare Data Center (CRHC-DC), Center for Clinical Trials & Data Coordination (CCDC), Division of General Internal Medicine, University of Pittsburgh School of Medicine, Circulation: Cardiovascular Interventions, Pittsburgh, PA. Electronic address: althousead@upmc.edu.
  • Chen E; Abbott, Chicago, IL. Electronic address: eric.chen1@abbott.com.
  • Cigarroa JE; Division of Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR. Electronic address: cigarroa@ohsu.edu.
  • DeVore AD; Duke University Medical Center, Duke Clinical Research Institute, Durham Veterans Administration, Durham, NC. Electronic address: adam.devore@duke.edu.
  • Farb A; U.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD.
  • Gilchrist IC; Pennsylvania State University, Heart and Vascular Institute, Hershey, PA. Electronic address: icg1@psu.edu.
  • Henry TD; The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, The Carl and Edyth Lindner Family Distinguished Chair in Clinical Research, The Christ Hospital Health Network, Cincinnati, OH. Electronic address: Tim.Henry@thechristhospital.com.
  • Hochman JS; NYU-HHC Clinical and Translational Science Institute, New York University School of Medicine, NYU Langone Health, New York, NY. Electronic address: Judith.Hochman@nyulangone.org.
  • Kapur NK; The CardioVascular Center, Tufts Medical Center Boston, MA. Electronic address: nkapur@tuftsmedicalcenter.org.
  • Morrow V; Duke Clinical Research Institute, Durham, NC. Electronic address: valarie.morrow@duke.edu.
  • Ohman EM; Duke Program for Advanced Coronary Disease, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC. Electronic address: erik.ohman@duke.edu.
  • O'Neill WW; Center for Structural Heart Disease, Division of Cardiology, Henry Ford Health System, Detroit, MI. Electronic address: WONEILL1@hfhs.org.
  • Piña IL; U.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD. Electronic address: ileana.pina@fda.hhs.gov.
  • Proudfoot AG; Department of Perioperative Medicine, St. Bartholomew's Hospital, London, United Kingdom. Electronic address: Alastair.Proudfoot@bartshealth.nhs.uk.
  • Sapirstein JS; U.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD. Electronic address: John.Sapirstein@fda.hhs.gov.
  • Seltzer JH; WCG-ACI Clinical, Bala Cynwyd, PA. Electronic address: jseltzer@aciclinical.com.
  • Senatore F; U.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD. Electronic address: fortunato.senatore@fda.hhs.gov.
  • Shinnar M; U.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD. Electronic address: Meir.Shinnar@fda.hhs.gov.
  • Simonton CA; Abiomed, Danvers, MA. Electronic address: csimonton@abiomed.com.
  • Tehrani BN; Virginia Heart, INOVA Heart and Vascular Institute, Alexandria, VA. Electronic address: behnamtehrani3@gmail.com.
  • Thiele H; Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology Leipzig, Germany, Leipzig Heart Institute, Leipzig, Germany. Electronic address: holger.thiele@medizin.uni-leipzig.de.
  • Truesdell AG; Virginia Heart, INOVA Heart and Vascular Institute, Alexandria, VA. Electronic address: agtruesdell@gmail.com.
  • Waksman R; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC. Electronic address: ronwaksman@gmail.com.
  • Rao SV; Duke University Medical Center, Duke Clinical Research Institute, Durham Veterans Administration, Durham, NC. Electronic address: sunil.rao@duke.edu.
Am Heart J ; 230: 93-97, 2020 12.
Article in En | MEDLINE | ID: mdl-33011148

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Shock, Cardiogenic / Heart-Assist Devices / Evidence-Based Medicine Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Am Heart J Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Shock, Cardiogenic / Heart-Assist Devices / Evidence-Based Medicine Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Am Heart J Year: 2020 Type: Article